12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Cano Health (CANO), YS Biopharma (YS), Aptorum Gr (APM), Impel Pharmaceuticals (IMPL), NeuroPace (NPCE), and Precigen (PGEN) saw increases in their stock prices. On the other hand, Longeveron Inc. - Subscription Right (LGVNR), Pieris Pharmaceuticals (PIRS), China SXT Pharmaceuticals (SXTC), NeuBase Therapeutics (NBSE), Mallinckrodt (MNK), and Minerva Surgical (UTRS) experienced declines.
August 25, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aptorum Gr's stock increased by 34.37% to $2.37.
The significant increase in Aptorum Gr's stock price is likely to have a positive short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Cano Health's stock rose 58.7% to $0.37.
The significant increase in Cano Health's stock price is likely to have a positive short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Impel Pharmaceuticals' stock increased by 20.22% to $0.53.
The significant increase in Impel Pharmaceuticals' stock price is likely to have a positive short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
NeuroPace's stock rose 17.82% to $6.08.
The significant increase in NeuroPace's stock price is likely to have a positive short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Precigen's stock increased by 14.05% to $1.75.
The significant increase in Precigen's stock price is likely to have a positive short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
YS Biopharma's stock increased by 41.19% to $1.1.
The significant increase in YS Biopharma's stock price is likely to have a positive short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Longeveron Inc. - Subscription Right's shares fell 43.6% to $0.02.
The significant decrease in Longeveron Inc. - Subscription Right's stock price is likely to have a negative short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt's stock declined by 17.78% to $0.33.
The significant decrease in Mallinckrodt's stock price is likely to have a negative short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
NeuBase Therapeutics' shares declined by 17.89% to $0.72.
The significant decrease in NeuBase Therapeutics' stock price is likely to have a negative short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Pieris Pharmaceuticals' shares fell 23.21% to $0.33.
The significant decrease in Pieris Pharmaceuticals' stock price is likely to have a negative short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
China SXT Pharmaceuticals' stock fell 19.41% to $0.12.
The significant decrease in China SXT Pharmaceuticals' stock price is likely to have a negative short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Minerva Surgical's shares fell 16.47% to $0.2.
The significant decrease in Minerva Surgical's stock price is likely to have a negative short-term impact on the asset.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100